Deep Track Capital, LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Deep Track Capital, LP disclosed 62 US equity positions worth $4.8bn in its Q1 2026 13F filing. The largest position was GH at 6.4% of the reported book, followed by IMVT and TARS.
What did Deep Track Capital, LP own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 6.4% | $308.4m | 3,338,241 | – | |
| 2 | IMVT IMMUNOVANT INC | Healthcare | 5.9% | $286.3m | 11,526,971 | – | |
| 3 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 5.2% | $252.5m | 3,600,000 | – | |
| 4 | PCVX VAXCYTE INC | Healthcare | 5.2% | $249.9m | 4,300,000 | – | |
| 5 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 4.3% | $206.3m | 4,279,848 | – | |
| 6 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 3.8% | $185.9m | 1,100,000 | – | |
| 7 | APLSUSD APELLIS PHARMACEUTICALS INC | 3.8% | $182.3m | 4,532,374 | – | ||
| 8 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.4% | $166.7m | 19,686,282 | – | |
| 9 | VERA VERA THERAPEUTICS INC | Healthcare | 3.4% | $165.2m | 4,106,067 | – | |
| 10 | ALMS ALUMIS INC | Healthcare | 3.1% | $149.2m | 6,772,595 | – | |
| 11 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 3.0% | $146.4m | 1,950,000 | – | |
| 12 | NUVALENT INC | 2.9% | $141.0m | 1,376,324 | – | ||
| 13 | ALKS ALKERMES PLC | Healthcare | 2.6% | $127.0m | 3,590,323 | – | |
| 14 | CNTA CENTESSA PHARMACEUTICALS PLC | 2.6% | $125.4m | 3,158,041 | – | ||
| 15 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 2.5% | $119.5m | 6,408,863 | – | |
| 16 | MAZE MAZE THERAPEUTICS INC | Healthcare | 2.1% | $103.8m | 3,477,562 | – | |
| 17 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 2.1% | $99.8m | 2,034,203 | – | |
| 18 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.0% | $98.4m | 6,345,244 | – | |
| 19 | GMAB GENMAB A/S | Healthcare | 2.0% | $98.3m | 3,663,250 | – | |
| 20 | CYTK CYTOKINETICS INC | Healthcare | 1.9% | $90.6m | 1,374,320 | – | |
| 21 | GRAL GRAIL INC | Healthcare | 1.8% | $89.0m | 1,722,797 | – | |
| 22 | LB PHARMACEUTICALS INC | 1.7% | $82.7m | 3,352,804 | – | ||
| 23 | MBX MBX BIOSCIENCES INC | Healthcare | 1.7% | $82.3m | 2,757,569 | – | |
| 24 | BCAX BICARA THERAPEUTICS INC | Healthcare | 1.7% | $80.8m | 4,062,500 | – | |
| 25 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.4% | $67.3m | 12,161,496 | – | |
| 26 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 1.3% | $65.0m | 1,150,000 | – | |
| 27 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.3% | $62.5m | 841,445 | – | |
| 28 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.2% | $58.2m | 1,931,884 | – | |
| 29 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.2% | $57.5m | 2,750,000 | – | |
| 30 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 1.2% | $56.7m | 3,000,000 | – | |
| 31 | 430 TERNS PHARMACEUTICALS INC | 1.2% | $56.6m | 1,073,877 | – | ||
| 32 | GERN GERON CORP | Healthcare | 1.0% | $47.3m | 31,720,278 | – | |
| 33 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.0% | $46.1m | 600,000 | – | |
| 34 | CRMD CORMEDIX INC | 0.9% | $42.6m | 6,274,076 | – | ||
| 35 | ATAI ATAIBECKLEY INC | 0.9% | $42.5m | 12,000,000 | – | ||
| 36 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.8% | $40.7m | 1,283,979 | – | |
| 37 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.8% | $38.5m | 1,000,000 | – | |
| 38 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 0.8% | $36.5m | 2,491,539 | – | |
| 39 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.7% | $36.3m | 2,000,000 | – | |
| 40 | SLNOEUR SOLENO THERAPEUTICS INC | 0.7% | $36.1m | 1,078,710 | – | ||
| 41 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.7% | $35.0m | 9,345,000 | – | |
| 42 | MANE VERADERMICS INC | Healthcare | 0.7% | $31.6m | 500,000 | – | |
| 43 | VSTM VERASTEM INC | Healthcare | 0.6% | $30.4m | 5,740,850 | – | |
| 44 | ENGENE HOLDINGS INC | 0.6% | $29.8m | 4,377,572 | – | ||
| 45 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.6% | $27.3m | 1,393,944 | – | |
| 46 | XFOR X4 PHARMACEUTICALS INC | 0.5% | $26.2m | 6,339,535 | – | ||
| 47 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.5% | $25.7m | 3,565,062 | – | |
| 48 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.5% | $24.7m | 1,956,867 | – | |
| 49 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.5% | $24.0m | 285,000 | – | |
| 50 | KURA KURA ONCOLOGY INC | Healthcare | 0.4% | $21.5m | 2,643,542 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.